As school districts grapple with surging demand for behavioral and special education services, New Story has launched a high-level advisory board. The group unites federal policy veterans and research leaders to refine evidence-based programming for more than 5,000 students currently served by the organization across seven states.
With the final whistle at MetLife Stadium, a massive security operation concluded, marked not just by the tournament's scale but by the logistical support provided to those on the perimeter. Over eight matches, 160 volunteers from the Rapid Relief Team sustained the law enforcement presence through long, high-pressure shifts.
Investors who purchased Planet Fitness, Inc. securities between November 6, 2025, and May 6, 2026, have until September 14, 2026, to file as lead plaintiffs in a newly initiated securities class action. The lawsuit follows a sharp 31% drop in share price triggered by a sudden reduction in the company's 2026 financial guidance.
Investors in Nano-X Imaging Ltd. are facing a court-imposed deadline to join a class action lawsuit following allegations that the company misled shareholders about the efficiency of its South Korean chip manufacturing facility between March 31, 2025, and April 17, 2026.
Institutional investors and fiduciaries holding Megan Holdings Limited securities during the firm's volatile 2025-2026 period face a September 8, 2026, deadline to seek lead plaintiff status in a federal class action lawsuit alleging a coordinated pump-and-dump market manipulation scheme.
Investors who held Futu Holdings Limited securities between May 24, 2023, and May 27, 2026, face an August 25, 2026, deadline to seek lead plaintiff status in a pending class action lawsuit. The litigation follows a sharp 27.5% share price drop triggered by reports of massive, previously undisclosed regulatory penalties.
August 11, 2026, marks the final window for Microsoft shareholders to petition as lead plaintiffs in a pending securities class action. The litigation, filed in the U.S. District Court for the Western District of Washington, targets alleged misrepresentations regarding the company’s AI initiatives and cloud integration performance.
Institutional investors holding Lucid Group, Inc. securities between February 25 and April 13, 2026, face an approaching July 28 deadline to seek lead plaintiff status. The pending class action centers on allegations that the automaker concealed significant supplier quality defects and manufacturing disruptions that led to a sharp stock decline.
Tampa-based contract lifecycle management firm IntelAgree has achieved co-sell readiness with Microsoft, enabling enterprise clients to purchase its AI-powered platform directly through the Microsoft Marketplace. The integration allows businesses to apply their existing Azure Consumption Commitments toward the software, effectively streamlining procurement within their established cloud budgets.
Verra Mobility Corporation investors are seeking damages through a pending class action lawsuit following a 71% stock plunge triggered by the abrupt termination of a major Avis Budget Group contract. The litigation centers on claims that the company misled shareholders regarding the stability of its rental car revenue streams.
A class action lawsuit has been filed against GeneDx Holdings Corp. after a May 2026 earnings disclosure triggered a 49% stock drop. The litigation alleges that the company artificially inflated its value by concealing material problems regarding the Fabric Genomics acquisition and declining reimbursement rates for its testing services.
Investors who purchased Intuit Inc. securities between August 22, 2025, and May 20, 2026, have until September 8, 2026, to seek lead plaintiff status in a pending securities class action. The lawsuit alleges the company concealed critical competitive and pricing pressures within its core TurboTax business.
Investors who purchased Peabody Energy Corporation stock between October 2024 and May 2026 are facing a class action lawsuit following allegations that the company misled shareholders regarding operational readiness at its Centurion mine and inflated key metallurgical coal production guidance.
Investors have initiated a class action lawsuit against Insulet Corporation, alleging the medical device manufacturer misled shareholders by touting robust quality controls while its Acton, Massachusetts facility produced roughly seven million flawed insulin pods. The litigation centers on disclosures made between February 2025 and May 2026.
A 50.55% collapse in Grail, Inc. shares on February 20, 2026, has triggered a securities class action lawsuit. The legal action centers on the company’s failure to meet primary endpoints in its NHS-Galleri trial, a development that wiped out $51.32 per share and shattered investor confidence in the firm's clinical projections.
Investors who incurred losses in Helen of Troy Limited between April 24, 2024, and October 8, 2025, have until August 3, 2026, to apply for lead plaintiff status. The ongoing litigation centers on allegations that management misled shareholders regarding the efficacy of the company’s restructuring initiative, Project Pegasus.
BitGo Holdings faces a securities class action lawsuit alleging that management’s repeated assurances of business resilience masked significant financial risks. Investors who purchased shares between January 22, 2025, and May 13, 2026, are now seeking recovery after the company’s stock price plummeted following disclosures of a $14.8 million net loss.
Investors who suffered losses in Badger Meter, Inc. have until August 3, 2026, to file for lead plaintiff status. The legal action follows a 24% single-day stock collapse on April 17, 2026, triggered by disclosures that revenue and demand metrics fell significantly short of previous management projections.
Investors have launched a class action lawsuit against ADMA Biologics, claiming the company masked a decline in ASCENIV sales through channel stuffing. The litigation targets public revenue projections made between August 2024 and March 2026, challenging the company’s assertion of robust 20% growth against evidence of a shrinking market share.
A federal securities class action is centering on former Hub Group CFO Kevin Beth, who allegedly oversaw a $77 million understatement of transportation costs. With the lead plaintiff deadline set for August 28, 2026, investors are scrutinizing financial certifications signed during a period of significant stock volatility.
Institutional investors who held AeroVironment shares between June 2025 and March 2026 are weighing lead plaintiff options following a collapse in stock value. The litigation centers on alleged misrepresentations regarding the company’s $1.7 billion SCAR contract, which culminated in a total contract termination and significant financial impairment.
Investors who purchased Regeneron Pharmaceuticals shares between August 1, 2025, and May 15, 2026, face a September 14, 2026, deadline to seek lead plaintiff status in a newly filed class action lawsuit regarding the company's handling of its Phase III Fianlimab-Libtayo clinical trial.
Investors who purchased Black Rock Coffee Bar securities between September 12, 2025, and May 12, 2026, face an August 17, 2026, deadline to serve as lead plaintiff in a class action lawsuit alleging the company misled shareholders regarding the impact of its rapid store expansion.
Investors who acquired Intuit Inc. securities between August 22, 2025, and May 20, 2026, are now eligible to participate in a class action lawsuit. The litigation alleges that the company misled shareholders regarding its competitive standing and the sustainability of its growth projections during that period.
More than 45,000 seniors in Maryland struggle with food insecurity, a crisis driven by fixed incomes and limited access to healthy options. To address this, Operation Pathways has received a 2026 Thome Aging Well Grant to implement a targeted food access program at two Baltimore residential properties.
Retail and consumer companies often struggle with specific, profit-draining challenges that neither a full-time executive hire nor a traditional consultant can effectively solve. The Convened, a new collective from Eunity Partners, intends to bridge this gap by embedding seasoned operators directly into firms to handle high-stakes execution until outcomes stabilize.
A first-in-human clinical study published in Nature reveals that C-CAR031, an armored CAR-T cell therapy, achieved tumor regression in nearly 90% of patients with heavily pretreated advanced hepatocellular carcinoma. The findings validate a novel approach to overcoming the immunosuppressive barriers typically found in solid tumors.
As experienced professionals retire, Pennsylvania American Water is attempting to secure the future of the state’s utility infrastructure by launching aggressive recruitment and mentorship initiatives. The company is betting on early-career exposure to bridge the widening gap between aging expertise and the next generation of essential water workers.
Before a dental implant can mimic the function of a natural tooth, it requires a stable environment: healthy gums and sufficient bone density. Dr. Danika Crabtree, a periodontist based in Warwick, Rhode Island, warns that skipping the foundational prep work often leads to implant instability or failure.
Two YMX Logistics executives, CEO Matt Yearling and Vice President Adam Buttgenbach, have earned spots as finalists for the 2026 Truck Fleet Innovator award. The recognition, presented by Heavy Duty Trucking, highlights their contributions to modernizing yard operations through electrification, artificial intelligence, and autonomous technology deployment.
